TWST
Twist Bioscience Corp
164.60$
-0.7%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 63.4% | 59.5% | 59.0% | 56.7% | 54.9% | 51.7% | 50.4% | 46.6% | 48.7% | 48.0% | 48.4% | 47.2% | 48.0% | |
| 36.6% | 40.5% | 41.0% | 43.3% | 45.1% | 48.3% | 49.6% | 53.4% | 51.3% | 52.0% | 51.6% | 52.8% | 52.0% | |
| 35.5% | 32.3% | 32.1% | 27.6% | 24.9% | 24.0% | 25.8% | 18.8% | 17.2% | 16.5% | 17.8% | 15.2% | 16.6% | |
| 66.5% | 73.9% | 73.9% | 69.7% | 62.7% | 63.3% | 68.6% | 66.0% | 57.3% | 67.4% | 68.7% | 68.2% | 65.7% | |
| 111.5% | 106.2% | 105.9% | 152.5% | 87.7% | 87.3% | 94.4% | 84.8% | 81.6% | 83.8% | 86.5% | 83.4% | 83.9% | |
| -74.9% | -65.7% | -64.9% | -109.2% | -42.5% | -39.1% | -44.8% | -31.4% | -30.2% | -31.7% | -34.9% | -30.6% | -31.9% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | – | – | – | – | – | – | |
| -69.4% | -60.0% | -60.0% | -104.8% | -40.8% | -35.5% | -42.2% | 21.4% | -27.2% | -29.2% | -39.7% | -29.3% | -31.5% | |
| -0.3% | 0.2% | 0.5% | 0.2% | -0.1% | 0.1% | 0.2% | 0.2% | 0.3% | 0.2% | 0.0% | -0.3% | 0.1% | |
| -69.1% | -60.2% | -60.4% | -105.0% | -40.9% | -35.6% | -42.4% | 21.2% | -27.4% | -29.4% | -39.8% | -29.6% | -31.7% | |
| -56.7% | -48.6% | -48.9% | -94.6% | -33.1% | -28.3% | -35.1% | 27.5% | -21.1% | -25.8% | -29.1% | -23.6% | -25.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.